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Abstract
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Background—One important objective for clinical trialists in rehabilitation is determining
efficacy of interventions to enhance motor behavior. In part, limitation in the precision of
measurement presents a challenge. The few valid, low-cost observational tools available to assess
motor behavior cannot escape the variability inherent in test administration and scoring. This is
especially true when there are multiple evaluators and raters as in the case of multi-site
randomized controlled trials (RCT). One way to enhance reliability and reduce variability is to
implement rigorous quality control (QC) procedures.
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California, 1540 Alcazar St., CHP 155, Los Angeles, CA 90089, USA. winstein@usc.edu, 323-442-3290.

Duff et al.

Page 2

Author Manuscript

Objective—This paper describes a systematic QC process used to refine the administration and
scoring procedures for the Wolf Motor Function Test (WMFT)-Functional Ability Scale (FAS).
Methods—The QC process, a systematic focus-group collaboration was developed and used for
a phase III RCT, which enlisted multiple evaluators and an experienced WMFT-FAS Rater Panel.
Results—After three staged refinements to the administration and scoring instructions, we
achieved a sufficiently high inter-rater reliability (weighted kappa = 0.8).

Author Manuscript

Conclusions/Implications—A systematic focus-group process was shown to be an effective
method to improve reliability of observational assessment tools for motor behavior in
neurorehabilitation. A reduction in noise-related variability in performance assessments will
increase power and potentially lower the number needed to treat. Improved precision of
measurement can lead to more cost effective and efficient clinical trials. Finally, we suggest that
improved precision in measures of motor behavior may provide more insight into recovery
mechanisms than a single measure of movement time alone.
Keywords
quality; observational; motor control; impairment; assessment; stroke

Introduction

Author Manuscript

Improvements in motor control or skill which can be causally linked to specific
interventions could inform clinical practice and perhaps more importantly, advance
knowledge about the mechanisms of recovery. The most robust measures of motor behavior
use laboratory-based instruments to record spatial-temporal parameters of position
(kinematics) and force (kinetics).1–3 However, these instrumented assessments are typically
costly, time consuming, and require specialized training and equipment for data collection
and analysis. As technology advances, more low-cost options with real-time capabilities will
become available.4,5 Yet, most researchers and some practitioners still rely on inexpensive,
low-technology measures such as the Wolf Motor Function Test (WMFT)6 and the Action
Research Arm Test (ARAT)7. These kinds of assessment tools can be subject to poor
reliability (i.e., increased variability), especially when used by multiple raters. Ultimately, a
diminished inter-rater reliability can reduce the statistical power for determining efficacy of
rehabilitative intervention studies.

Author Manuscript

One way to control for the inherent risk of diminished inter-rater reliability is through
quality control (QC) procedures. The WMFT6 is a standardized, performance-based, upper
extremity (UE) assessment of functional capability for adults post-stroke that includes 15
timed items and 2 strength items. From video-capture, a discrete WMFT-Functional Ability
Scale (FAS) score is determined post-hoc to quantify the quality of movement (relative to
the less affected side) for each of the 15 timed tasks. The score is based on characteristics of
speed, precision, coordination and fluidity--metrics of skill.8 The WMFT-FAS uses a 6point ordinal rating scale that ranges from 0 (no use of the affected side attempted) to 5
(normal) for a maximum score of 75 for the fifteen tasks. The psychometric properties of the
WMFT-FAS were previously explored in three related papers.8–10 The minimal detectable
change (MDC90) was reported to be 0.37 (range 0.2–0.4) points per task8 within an overall
Neurorehabil Neural Repair. Author manuscript; available in PMC 2016 June 01.
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change of 20 out of 75 points (27%) (MDC95) across tasks.10 Morris and colleagues8 found
the inter-rater reliability (ICC) to be ≥ 0.88 when task items were pooled, yet there was
inconsistency for individual tasks with median ICCs that ranged from 0.36 to 0.93.
The Interdisciplinary Comprehensive Arm Rehabilitation Evaluation (ICARE) phase III
multi-site randomized controlled trial11 afforded an opportunity to implement a rigorous QC
process. This effort was undertaken to strengthen inter-rater reliability of the Rater Panel
scores and thereby improve construct validity of the WMFT-FAS for the ICARE trial. Our
process resulted in a fine-tuned revision to the administration and scoring instructions (ASI,
see Supplementary Material). Ultimately, our aim is to inform clinical investigators about
the QC process and to provide the revised ASI to future users.

Methods
Author Manuscript

Organization of the Phase III Clinical Trial
The ICARE trial with targeted enrollment of 360 participants is a prospective phase III RCT
that includes three regional centers (Los Angeles, Washington DC, and Atlanta) and 7
clinical sites (5 in Los Angeles, and 1 each in Washington DC and Atlanta).11 The primary
aim of ICARE is to compare arm and hand recovery in adults early post-stroke who are
randomized to one of three groups. The experimental group participates in an outpatient
structured therapy program termed the Accelerated Skill Acquisition Program (ASAP) and
are compared to those randomized to a dose equivalent usual and customary therapy
program.

Author Manuscript

The primary outcome is the change in the log-transformed WMFT time score at one-year
post-randomization. The WMFT-FAS is but one of a large battery of secondary outcomes.
As with other multi-site studies, the ICARE trial requires considerable coordination, training
and standardization of multiple team members to ensure success. Each site has a team leader
and usually one reserve, while each regional center has multiple blinded evaluators (BEs)
who formally administer the ICARE assessment battery at each of four designated time
points. The Administrative Core employs 3 experienced clinicians (Rater Panel) who rate
the fifteen timed tasks from digitally captured footage. Data are collected and managed
through the primary database hosted by the central Data Management and Analysis Center
(DMAC) and the File Transfer Protocol (FTP) site hosted by the Administrative Core at the
University of Southern California in Los Angeles. The flow of data from test administration
to rating score submission is illustrated in Figure 1.

Author Manuscript

Licensed occupational and physical therapists blinded to group assignment, administer the
WMFT at baseline and post-randomization at 3 pre-determined follow-up periods: posttherapy, 6 months, and 1 year. The WMFT is filmed using a digital camera (standardized
across sites) according to detailed procedures outlined in the ICARE Manual of Procedures
(MOP). Prior to study initiation, site-designated BEs attended a 3-day Clinical Research
Evaluators Training Meeting in Los Angeles. Training materials and protocols, with video
demonstrations are updated when necessary and made available on a secure ICARE web site
for ongoing review and use by BEs and other study personnel. Test administration
certification requires each BE to demonstrate at least 90% proficiency with the standardized
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administration and scoring criteria. Re-certification is required every 6 months until data
collection is complete.
Immediately after test administration, the local site edits the digital file and uploads it to a
secure FTP server. A trained member of the Administrative Core evaluates and approves
each de-identified digital file for quality (i.e., data completeness, audio and visual clarity)
and consistency with the ASI essential elements (see Results for details on essential
elements). Once the QC check is complete, the digital files are made available to the Rater
Panel. Files that fail the QC check are retained and depending on the reason may go back to
the BE for remediation. In any case, the test is not re-administered. Failed files are returned
to BE’s if deemed fixable. For example, if the problem was in editing, the BE can re-edit the
digital file from the raw footage. Most importantly, feedback is given to sites to ensure that
the same error does not recur, regardless of the reason for failure.

Author Manuscript

The Rater Panel scores each digitally recorded assessment using the 6-point scale. Initially,
panel members independently determined a score for each task. This yielded 3 ratings per
task for each digital file (i.e., 15 tasks × 3 raters = 45 scores/test). Thus, without attrition we
estimated ~1440 digital files (360 participants × 4 time points) at ~ 30–45 minutes/each for
accurate scores per rater.
Timeline for QC Process

Author Manuscript

To improve consistency in test administration across sites and to verify the reliability of
WMFT-FAS scoring, the ICARE clinical leadership in collaboration with the BEs and Rater
Panel implemented a QC process. Prominent events of the systematic QC process included:
refinement of the WMFT template (i.e. table-top mat), clarification and refinement of the
ASI, statistical analysis of the Rater Panel scores and initiation of monthly Rater Panel
meetings. These events are chronicled in Figure 2.
Three revisions were made to the ASI to simplify instructions, specify the set-up and reduce
scoring ambiguity (see Results for details). After each revision, the changes were reviewed
in meetings held with the site team leaders, BEs and Rater Panel members. Each site and BE
provided signed documentation that the revised protocols were reviewed and replaced in the
MOP binders; master copies were also available through the secure ICARE web site.

Author Manuscript

In concert with the ASI revisions, the DMAC conducted five rounds of inter-rater reliability
testing based on scores generated by the Rater Panel. The first two rounds used digital files
from a prior study completed before ICARE and the later three rounds used digital files from
the ICARE trial itself. Each panel member rated the digital files and submitted their scores
to the DMAC through the secure FTP site.
Monthly web-based meetings of the Rater Panel began after round 2 of reliability testing.
These meetings were initiated in an effort to hone the panel’s objective rating skills and to
identify scoring criteria that needed clarification. After independent review of sample digital
files, discrepancies in rating were identified by the DMAC. Each rater shared the decision
process they used to rate discrepant items and a meaningful discussion ensued. During
meetings boundaries for determining whether a task was performed “very slowly (score 2),
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slower (score 3), or slightly slower (score 4)” were discussed and differences between raters
on specific task scores (identified by the DMAC) were reviewed. An examination of the
boundaries for each scoring category included a review of the actual movement time of task
performance and a comparison with the less-involved limb’s performance. However, a
specific time interval for each category was not designated because, in most cases, it was
determined relative to the less-involved limb. Specific instructions about the WMFT FAS
rating and the speed of movement are included in the ASI (Supplementary Material, Section
VI.B.) in the section beginning, “For determination of normal…” The rater panel agreed that
the difference between speed categories was best determined through examples and
discussion during the monthly meetings. Discrepancies were adjudicated by majority vote.
Statistical Analysis

Author Manuscript

Inter-rater reliability was assessed using the weighted kappa for all five rounds of testing.
Weighted kappa (kw) is a measure of concordance for ordinal outcomes that weights larger
disparities in ratings higher than smaller differences, 12–13 that was appropriate given the 6point scaling. A quadratic weighting was used for these analyses in order to penalize greater
discordance in ratings more severely than would occur with a linear weighting. For example,
a difference in ratings of a 2 and a 3 would be seen as a much smaller disparity in rating than
a difference in rating between a 2 and a 5. Weighted kappa was utilized, as the items under
review were ordinal. While ICCs are appropriate for interval level data, they are
inappropriate for ordinal level data, as they require calculation of parametric outcomes that
are not meaningful in non-parametric data. To guide our efforts toward the achievement of
inter-rater reliability, we looked to the “benchmarks” that Landis and Koch14 used and set a
lower bound of 0.80, which should represent “substantial” agreement.

Author Manuscript

Results
Revisions to Administration and Scoring Instructions
The initial version of the ASI adopted for the ICARE MOP was the same as that used in the
EXCITE trial.15 Prior to randomization for ICARE, Revision 1 was made to the original
table-top template and the ASI (Figure 2). Instructions on positioning for task execution and
camera placement were revised and placement markers for each item were labeled on the
template. Participant instructions for the quick demonstrations were condensed for all items.
For example, for Item #10 the instructions for the quick demonstration now reads, “Pick up
the pencil as fast as you can.”

Author Manuscript

Revision 2 of the ASI was completed after randomization commenced. Refinements
included specifications on chair positions, participant/object proportions (i.e., box size) and
filming strategies. For example, the filming position “Side-Close” was specified to zoom in
on fine-motor skills. Instructions for task items were also clarified. For example, for Item
#12 Stack checkers, we added, “Do it like this (demonstrate correct method), not like this
(demonstrate incorrect method of at least one checker still touching the table surface in the
stacked position).” Finally, a description of template placement during test administration
was added.

Neurorehabil Neural Repair. Author manuscript; available in PMC 2016 June 01.
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Revision 3 was finished after round 4 of statistical testing and included clarification of the
scoring criteria and the addition of ‘essential’ and ‘desirable’ elements for each item.
Essential elements are the specific features that must be accomplished in order for the task to
be deemed ‘complete’. The desirable elements are other qualitative features that should be
included in the task but are not necessary for completion. If a participant cannot complete
the essential elements they are given a timed score of 120+ (coded as −7). An essential
element in Item #15 Turing key in lock, reads, “Turns key fully each direction and back to
vertical”. Two desirable elements for Item #15 are, “lateral pinch and turns key to the
instructed direction first”. Revision 3 also included photos of task demonstrations. In the
General Comments section details were added such as, “If a BE makes a mistake with set-up
or timing, the task may be repeated an additional time”. Consultation with investigators from
the EXCITE trial and the BE team at Emory University guided the third ASI revision.

Author Manuscript

Reliability Testing—Reliability testing began during the Rater Panel’s training period.
The five rounds of testing were interspersed with ASI revisions, review of previous
reliability findings, consultation with WMFT-FAS experts and quality checks of digital files
(Figure 2). The timeline reveals that this process transpired over a 3-year period.

Author Manuscript

In round 1, some kw values between raters were below our 0.8 criterion (0.67 to 0.83).
Therefore, the ICARE leadership team consulted the reliability findings from Morris et al.8
The pooled reliability was reportedly high,8 but the inter-rater reliability for more than half
of the tasks was lower than the 0.80 criterion set for the ICARE trial.8 For at least one of two
test periods, inter-rater reliability for 9/15 tasks was < 0.75 and ICCs for a number of tasks
(i.e., #1, 4, 7, 10 and 11, see Figure 3 legend for task ID) were <0.50.8 This important factor
contributed to our decision to seek to improve inter-rater reliability to a greater level than
round 1 of ICARE and that reported by Morris et al.8
For round 2, inter-rater reliability was inconsistent (kw values 0.62 to 0.87). Only one rater
pair (raters 2 and 3) reached the kw criteria of 0.80 in the first two rounds of statistical
testing (Figure 2). Therefore, the ICARE clinical leadership team, in collaboration with the
DMAC, requested that each Rater Panel member score every ICARE digital file (i.e., 3
scores per file) and meet as a group once/month to review and adjudicate task items with
between rater scoring discrepancies.

Author Manuscript

For round 3 all kw values (0.76 to 0.89) were higher than for round 2. Yet, round 4 kw values
showed a reduction in agreement between rater 2 and the other two raters (0.51 and 0.66)
compared with the first three rounds. Additional QC methods were then pursued to examine
the basis for the diminished reliability. This involved a heightened screening process in
which the digital files were reviewed for confirmation of clear visibility of the essential task
elements and accuracy of editing. After round 4, the ASI underwent a 3rd and final
refinement.
For round 5, the kw pooled reliability was above criterion (0.81 to 0.86). Yet, the kw
between raters for the fifteen tasks in round 5 was less consistent (Figure 3). Three tasks fell
below a kw of 0.70 for at least two rater pairs including; “Forearm to table” (#1; 0.66),
“Forearm to box” (#2; 0.66), and “Reach and retrieve” (#8; 0.63). Of note, these 3 tasks

Neurorehabil Neural Repair. Author manuscript; available in PMC 2016 June 01.

Duff et al.

Page 7

Author Manuscript

were among those Morris et al.8 found to have a low level of agreement on at least one of
two test periods (#1 = 0.52; #2 = 0.57; #8 = 0.61). For ICARE, raters 1 and 3 had the highest
agreement (kw > 0.7 all tasks) and raters 2 and 3 had the lowest agreement for the “Reach
and retrieve” task (#8 = 0.63). It is important to note that a kappa value of 0.80 is a very
stringent cutoff, representing almost perfect alignment of scores. Kappa’s > 0.60 are
considered very highly associated.
Once an inter-rater weighted kappa ≥ 0.8 was achieved by round 5 for the pooled tasks, 90%
of the digital files were each assigned to only one rater with ~10% (randomly selected by the
DMAC) distributed to all 3 raters for independent scoring. This shift in allocation from
three- to one-rater per digital file reduced the time and cost of the rating process. Periodic
examination of rater reliability (10% of digital files) has demonstrated that inter-rater
reliability is being maintained at levels > kw = 0.70, with most > 0.80.

Author Manuscript

Discussion
Findings from recent multi-site definitive neurorehabilitation RCTs have been less
optimistic than the phase II trials that preceded them;16–19 primarily because it is difficult to
replicate the group differences from smaller scale trials in multi-site large scale trials.20–22
This phenomenon may be due at least in part, to the inherent confounding factors introduced
when conducting bench to bedside work, and the lower methodological rigor often tolerated
in smaller single-site compared with larger multi-site trials.20–23 This paper focuses on one
potential confounder--random error introduced during administration and scoring of an
observationally-based motor behavior assessment. Improved inter-rater reliability is one way
to increase the sensitivity of these types of measures in multi-site RCTs.

Author Manuscript

The ICARE trial was powered on the log WMFT-time score, the primary outcome variable
that will be used to determine the efficacy of the experimental therapy protocol.11 The QC
process we describe here was implemented for one of the secondary outcome measures—
one that will be important for interpreting changes in the WMFT time score. The systematic
QC process included modifications to the ASI criteria and quality checks of digital files.
This process likely elevated the construct validity of this secondary outcome measure.
Clinicians and researchers who wish to establish substantial agreement in using the WMFTFAS should find the details and knowledge gained by the ICARE team particularly helpful
for future endeavors.

Author Manuscript

There is no doubt that the QC process we describe is time consuming, costly, and requires
considerable resources to implement. Given that the WMFT-FAS was a secondary outcome
measure, why implement such a rigorous, resource-consuming process? What might be the
benefit of improved inter-rater reliability? Recently, See and colleagues24 showed that a
standardized training approach used with examiners for a phase II controlled trial
significantly reduced variability in scoring on the Fugl-Meyer Assessment (FMA) UE Scale.
Data analysis revealed that the improved reliability on the FMA decreased the variance in
scoring by 20%. In turn, a 20% reduction in variance on the FMA would allow a reduction
in sample size from 137 to 88 to detect group differences for a trial powered at 80%.24 For
the ICARE Trial, an improved WMFT-FAS inter-rater reliability could effectively
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strengthen the sensitivity to detect group differences. However we cannot know the possible
impact on ICARE until we are permitted to analyze group data (expected, August, 2014).
For studies in which the WMFT-FAS is a primary measure,25–27 an improved reliability
could lead to increased power. As shown recently, even small decreases in variability can
have a large effect on the sample size required to detect a statistically significant effect.23
Furthermore, a decrease in sample size could have a very large effect on the cost of
conducting a clinical trial. Use of the revised WMFT ASI (Supplementary Material) could
minimize the need for an extensive QC effort, decrease the cost and increase the efficiency
of future single- and multi-site clinical trials in stroke rehabilitation.

Author Manuscript

Recently, Woodbury and colleagues28 used Rasch analysis to establish a hierarchy of item
difficulty for 14/15 items based on the rating scale of the WMFT-FAS. From that analysis
the authors discovered that Item #8, “Reach and retrieve”, had abnormally high missing
values due to administration and filming errors. Without this item the authors were able to
establish an item difficulty hierarchy to show that higher scores on difficult items were
associated with higher UE function. For ICARE, greater reliability and precision of the
WMFT-FAS score will be important for determining whether the structured intervention
significantly contributed to an improvement in UE motor behavior and skill above that
achieved for the dose equivalent usual and customary treatment group.
Limitations

Author Manuscript

One limitation was that initially we relied on the inter-rater reliability of the WMFT-FAS
reported in Morris et al8 and assumed that we would achieve the same if not a higher rater
agreement level. After round 1 of reliability testing and closer examination of the findings
for individual items in Morris and colleagues8 we realized that this assumption was
incorrect. In hindsight, we should have scrutinized previous results more carefully before
conducting round 1. This may have allowed us to initiate strategies to improve inter-rater
reliability earlier in the trial.

Author Manuscript

Another limitation is that we assumed that the initial in-person training provided to the
blinded evaluators would be sufficient. However, over the course of the trial new BE’s who
joined the team did not receive this in-person training; although they did have web site
access to training materials, protocols, video demonstrations and in person local experienced
BEs. In previous work, the investigators suggested that evaluator training may have been
insufficient due to the low agreement level for many items8. See and colleagues24 showed
that standardized training and testing after training increased reliability of the FMA. We
speculate that in-person training and greater scrutiny of the knowledge and skill of all BE’s
could have improved consistency in WMFT execution and may have hastened the
achievement of inter-rater reliability.
A final limitation pertains to the web-based group meetings of the Rater Panel. Although
this process was deemed beneficial overall, we note that there was an initial familiarization
period that may have adversely influenced individual scoring strategies and subsequent
ratings assigned by the panel members. Initially, the raters reported a tendency to second
guess their first responses and predict how the other raters would score. This context effect
dissipated with time and familiarization with the process.
Neurorehabil Neural Repair. Author manuscript; available in PMC 2016 June 01.
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From this systematic QC process we offer a few recommendations to investigators who plan
to use the WMFT-FAS in their clinical trial research. 1) The quality of the visual media
capture is critical. As such, close attention to the camera setup is strongly recommended to
assure sufficient visualization of the essential and desirable elements (see Supplementary
Material). 2) Frequent and consistent (pre-planned) web-based Rater Panel focus-group
meetings are recommended to sharpen rater skills, foster consistency in scoring and maintain
these skills over the entire course of the study. 3) Implementation of regular meetings for the
blinded evaluators is recommended to maintain consistency in test execution over time and
across sites. Remote meeting formats such as Go-to-Meeting, WebEx or Adobe Connect are
useful for recommendations 2 and 3. 4) To further strengthen inter-rater reliability of the
WMFT-FAS we recommend removal of the most problematic items in future revisions
including: Forearm to table (#1); Forearm to box (#2); and Reach and retrieve (#8) (see
rationale in Results).8,11,28 While standardization procedures are common for
implementation of clinical trials research, the first two recommendations are unique aspects
of QC enforced in the ICARE study. Finally, we suggest that the first three
recommendations can be generalized for use with comparable quality-based motor
performance measures in the context of multi-site RCTs.

Conclusions/Implications

Author Manuscript

The effort expended to modify the ASI procedures and achieve a substantial level of interrater reliability likely enhanced the construct validity of the WMFT-FAS instrument. We
detail the systematic QC process developed for ICARE so that others may benefit from a
more sensitive and objective measure of motor behavior. We believe that the process of
strengthening the psychometric properties of observationally based motor behavior measures
is vital to advancing the science of our field and to enhancing our understanding of the
mechanisms of recovery. This concern is timely given the recent fervent discussions
surrounding the nature of sub-optimal motor recovery (recovery vs. compensatory) 29–32 and
impairment-based vs. task-based intervention protocols.1,33 As the number of clinical trials
in neurorehabilitation grows and we attempt to demonstrate sufficient efficacy and
effectiveness of our interventions, it is essential that we use reliable tools that provide
information pertaining to restitution and substitution strategies.

Author Manuscript

Observational measures that provide reliable information about ‘how the movement was
performed’ with the addition of temporal measures (e.g., movement time) could offer new
insights about the recovery process. The WMFT-FAS complements the WMFT-time score.
Thus, we would ideally like the scores from both measures to improve. Yet, discrepancies
may provide greater insight.34 For example, if movement time decreases while the WMFTFAS score is unchanged, this may suggest that the improvement stems from sub-optimal
compensatory strategies. Therefore, complementary measures of motor behavior and
movement time should be used to better understand the mechanisms of recovery that are
impacted by rehabilitative interventions.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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ASAP

Accelerated Skill Acquisition Program

ASI

Administration and scoring instructions

DMAC

Data Management and Analysis Center

BE

Blinded Evaluator

FAS

Functional Ability Scale

ICARE

Interdisciplinary Comprehensive Arm Rehabilitation Evaluation

ID

Identity

ICCs

Interclass correlations

MOP

Manual of Procedures

QC

Quality control

UE

Upper Extremity

WMFT

Wolf Motor Function Test
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Flow diagram. The flow of data from initial administration of the WMFT by the BE to
uploading of scores to the FTP site by the Rater Panel member is shown. WMFT = Wolf
Motor Function Test, BE = Blinded Evaluator, FTP = File Transfer Protocol.
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Figure 2.
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Timeline for systematic quality control process. Top – Inter-rater reliability (quadratic
weighted kappa) for the WMFT-FAS Rater Panel overall for each round of analysis for each
of the three rater pairs. The number of digital files (n) included in each round is listed.
Bottom – Timeline of events (with dates) for the ICARE trial including revisions to the
WMFT-FAS administration and scoring instructions (ASI) and other notable events before,
during and after the 5 rounds of analysis. QCh = quality check conducted to ensure essential
elements were met for each digital file.
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Figure 3.
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Inter-rater reliability by task at Round 5. The quadratic weighted kappa values between
members of the WMFT-FAS Rater Panel are shown for each task. The fifteen timed tasks
are: 1) Forearm to table; 2) Forearm to box; 3) Extend elbow; 4) Extend elbow with weight;
5) Hand to table; 6) Hand to box; 8) Reach and retrieve; 9) Lift can; 10) Lift pencil; 11) Lift
paper clip; 12) Stack checkers; 13) Flip cards; 15) Turning key in lock; 16) Fold towel; and
17) Lift basket. [Note that the two force tasks are not listed, but the full WMFT task
numbering has been retained].
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